# Picard Medical, Inc. (PMI) · Edgar & Edgarette company card

> Picard Medical (PMI) grew revenue 12.5% in FY2025 to $5 million, operating margin -268% against a 1.2% median for surgical & medical instruments & apparatus, equity 16.8% of assets. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 2030617 · fiscal year ended 2025-12-31 · 2 audited years read · [page](https://www.pops4.com/boards/company/PMI) · [JSON](https://www.pops4.com/boards/company/PMI.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $5M |
| Revenue growth, 1 year | 12.5% |
| Revenue growth per year | — |
| Operating margin | -268.4% (prior year -312.3%) |
| Net margin | -546.6% |
| Operating cash flow | −$16M |
| Capital spending | — |
| Free cash flow | — |
| Cash | $7M |
| Long-term debt | — |
| Total assets | $23M |
| Total equity | $4M |
| Equity ÷ assets | 16.8% |
| Return on equity | -712.6% |
| Dividend per share | — |
| Dividend years rising | — |

## Readings, computed from those figures

- Altman Z: -14.26 (distress zone)
- Piotroski F: 4 of 9 (middling)
- Health Harbor boat: Rotting at the dock · four or more warning signs · filed late quarterly report notice in the last 12 months; operating cash flow was negative (-$15.7M in FY2025); operating loss: a margin of -268.4% in FY2025; revenue is hard to predict: its 80% range is ±28%

## Edgarette's reading

Exposure: revenue $4.9M (FY2025). Experience: revenue up 12.5% on the year; operating margin -268.4%, up from -312.3%. Soundness: equity 16.8% of assets, return on equity -712.6%. Credibility: 2 audited years, moderate weight. Range: 80% of past cases like this landed between $4.1M and $7.3M next year (method v3, set from 749 SEC company-years; on a year the method never saw, 83% landed inside). A statistical range, not company guidance. Against peers (60 filers, $50M+ revenue, surgical & medical instruments & apparatus): operating margin -268.4% against a 1.2% median; growth 12.5% against 11.6%.

Range logged 2026-10-14, receipt f19f6286bc415eee, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 3.01 Exchange listing notice or transfer: 3, latest 2026-07-27 ([filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926024465/0001437749-26-024465-index.htm))
- Item NT 10-Q Late quarterly report notice: 1, latest 2026-08-17 ([filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926028093/0001437749-26-028093-index.htm))
- Item 5.02 Director or officer change: 4, latest 2026-11-03 ([filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926034708/0001437749-26-034708-index.htm))

## Recent filings

- 10-Q · filed 2026-11-16 · [filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926037258/0001437749-26-037258-index.htm)
- 8-K · filed 2026-11-03 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926034708/0001437749-26-034708-index.htm)
- 8-K · filed 2026-10-23 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926033423/0001437749-26-033423-index.htm)
- 8-K · filed 2026-10-13 · 5.03 Amendments to Articles or Bylaws; Change in Fiscal Year; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926032542/0001437749-26-032542-index.htm)
- 8-K · filed 2026-10-06 · 2.03 Creation of a Direct Financial Obligation; 3.02 Unregistered Sales of Equity Securities; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926032125/0001437749-26-032125-index.htm)
- 8-K · filed 2026-08-20 · 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/2030617/000143774926028585/0001437749-26-028585-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0002030617.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2030617

## Cite

POPS4, Edgar & Edgarette: Picard Medical, Inc. (PMI) company card, from the company's own SEC filings, accessed 2026-11-19, https://www.pops4.com/boards/company/PMI. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.

